Related references
Note: Only part of the references are listed.Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma
Cheong A. Bae et al.
GASTRIC CANCER (2020)
Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Canan Kasikara et al.
CANCER RESEARCH (2019)
Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
Yoko Tsukita et al.
MOLECULAR CANCER (2019)
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells
Weng Hua Khoo et al.
BLOOD (2019)
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
Kayla V. Myers et al.
MOLECULAR CANCER (2019)
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
Gabriele D'Errico et al.
ONCOGENE (2019)
Axl signaling is an important mediator of tumor angiogenesis
Mai Tanaka et al.
Oncotarget (2019)
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma
Alisha Holtzhausen et al.
CANCER IMMUNOLOGY RESEARCH (2019)
S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma
Yiren Xiao et al.
CANCER RESEARCH (2019)
Soluble AXL is ubiquitously present in malignant serous effusions
Marine Flem Karlsen et al.
GYNECOLOGIC ONCOLOGY (2019)
Stromal Gas6 promotes the progression of premalignant mammary cells
Angelica M. Gomes et al.
ONCOGENE (2019)
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi et al.
NATURE COMMUNICATIONS (2019)
Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer
Victoria H. Cruz et al.
JCI INSIGHT (2019)
Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan
Chiara Fedeli et al.
JOURNAL OF VIROLOGY (2018)
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis
Milena S. Espindola et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro et al.
CANCER RESEARCH (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Stromal cells in breast cancer as a potential therapeutic target
Samantha S. Dykes et al.
Oncotarget (2018)
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette et al.
CELL REPORTS (2018)
Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization
Gaetano Zizzo et al.
INFLAMMATION (2018)
Gas6 is dispensable for pubertal mammary gland development
Kylie L. Mills et al.
PLOS ONE (2018)
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
Kathleen F. Ludwig et al.
CANCER RESEARCH (2018)
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
Canan Kasikara et al.
MOLECULAR CANCER RESEARCH (2017)
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
Mirko Dengler et al.
ONCOTARGET (2017)
Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
Zhiqiang Guo et al.
ONCOTARGET (2017)
Macrophages promote the progression of premalignant mammary lesions to invasive cancer
Emily C. Carron et al.
ONCOTARGET (2017)
Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy
Ryu Kanzaki et al.
SCIENTIFIC REPORTS (2017)
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
Pinar Kanlikilicer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma
Kuo-Tai Hua et al.
SCIENTIFIC REPORTS (2017)
Giving AXL the axe: targeting AXL in human malignancy
Carl M. Gay et al.
BRITISH JOURNAL OF CANCER (2017)
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Reprogramming the immunological microenvironment through radiation and targeting Axl
Todd A. Aguilera et al.
NATURE COMMUNICATIONS (2016)
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
Miles A. Miller et al.
CANCER DISCOVERY (2016)
Liver X receptor and STAT1 cooperate downstream of Gas6/Mer to induce anti-inflammatory arginase 2 expression in macrophages
Si-Yoon Kim et al.
SCIENTIFIC REPORTS (2016)
The Receptor Tyrosine Kinase AXL in Cancer Progression
Erinn B. Rankin et al.
CANCERS (2016)
TAM Receptor Signaling in Immune Homeostasis
Carla V. Rothlin et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Catherine Wilson et al.
CANCER RESEARCH (2014)
An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo
Manikandan Subramanian et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Axl Receptor Blockade Ameliorates Pulmonary Pathology Resulting from Primary Viral Infection and Viral Exacerbation of Asthma
Takehiko Shibata et al.
JOURNAL OF IMMUNOLOGY (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Erinn B. Rankin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Axl as a mediator of cellular growth and survival
Haley Axelrod et al.
ONCOTARGET (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis
Guo-Xiang Ruan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival
Smita Salian-Mehta et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Aaron S. Meyer et al.
SCIENCE SIGNALING (2013)
Axl is essential for VEGF-A-dependent activation of PI3K/Akt
Guo-Xiang Ruan et al.
EMBO JOURNAL (2012)
Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages
Tingting Deng et al.
IMMUNOLOGY (2012)
Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Anjali Mishra et al.
MOLECULAR CANCER RESEARCH (2012)
Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
Jessica E. Brown et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Jeremy D. Waight et al.
PLOS ONE (2011)
Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
Sonja Loges et al.
BLOOD (2010)
GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche
Yusuke Shiozawa et al.
EXPERIMENTAL HEMATOLOGY (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
Paradoxical Roles of IL-4 in Tumor Immunity
Zhiguang Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival
Anna Gustafsson et al.
CLINICAL CANCER RESEARCH (2009)
Survival and Migration of Human Dendritic Cells Are Regulated by an IFN-alpha-Inducible Axl/Gas6 Pathway
Sara Scutera et al.
JOURNAL OF IMMUNOLOGY (2009)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis
Peter Vaupel
ONCOLOGIST (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells
Heather M. Seitz et al.
JOURNAL OF IMMUNOLOGY (2007)
SOCS proteins, cytokine signalling and immune regulation
Akihiko Yoshimura et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Twist mediates suppression of inflammation by type IIFNs and Axl
M. Nusrat Sharif et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Structural basis for Gas6-Axl signalling
T Sasaki et al.
EMBO JOURNAL (2006)
Expression of Axl in lung adenocarcinoma and correlation with tumor progression
YS Shieh et al.
NEOPLASIA (2005)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses
WR Gould et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
M Gallicchio et al.
BLOOD (2005)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins
MD Huang et al.
NATURE STRUCTURAL BIOLOGY (2003)
Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6 -: Receptor tyrosine kinase activation by laminin G-like domains
T Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
